# Gate Status — 2026-08-13 (Gate-B execution)

## Gate A — Problem Definition: PASS (narrowed)

The broad novelty claim was reduced after systematic 2026 comparison. Current research position is **PARTIAL NOVELTY ONLY**: a six-level cross-domain intervention-control measurement framework with explicit WAIT/silence, permission/autonomy separation, and asymmetric error costs. Independent annotation must still show the distinctions are measurable.

## Gate B — Benchmark Validity: BLOCKED_BY_INDEPENDENT_ANNOTATION

### Evidence completed

- pilot_v0 retained and formally retired from ranking after its structural leakage failure;
- 144-scenario development_v1 built across six domains;
- 24 counterfactual pairs and six temporal sequences created with hidden metadata separated from policy/annotator input;
- raw-context primary track added to reduce engineered-label leakage;
- pre-annotation leakage suite executed and passed: 0 exact duplicates, 0 structural duplicates, 0 unrelated >=0.90 near duplicates, 0 hidden-metadata findings;
- blinded annotation packets A/B generated in different orders;
- annotation parser, agreement, disagreement, and metric tooling implemented;
- metric denominators defined, including corrected unsafe-autonomy denominator;
- local tests: 10 passed;
- local development_v1 validation: 144 valid unique scenarios.

### Blocking evidence

- genuinely independent human annotations: NOT EXECUTED;
- raw agreement >= 0.80: NOT EXECUTED;
- Cohen's kappa >= 0.60: NOT EXECUTED;
- label-dependent lexical audit: NOT_EXECUTED_NO_INDEPENDENT_LABELS;
- shuffled/corrupted-feature control: FRAMEWORK_PENDING_LABELS.

Gate B must not be marked PASS until these are completed.

## Gates C–H

BLOCKED BY GATE ORDER. No formal baseline leaderboard, candidate tuning, protected evaluation, robustness claim, ablation claim, or final research-support claim has been executed.

## Evidence-weighted completion

| Evidence area | Weight | Supported now |
|---|---:|---:|
| Problem definition | 10% | 10% |
| Benchmark validity | 20% | 11% |
| Baseline integrity | 15% | 0% |
| Candidate evidence | 15% | 0% |
| Protected validation | 15% | 0% |
| Robustness | 10% | 0% |
| Ablation | 10% | 0% |
| Reproducibility | 5% | 4% |
| **Total** | **100%** | **25%** |

Reproducibility remains conservatively scored 4/5 even with CI because an independent clean-machine reproduction audit has not yet been performed. This score does not award Gate-B completion for unexecuted human evidence.
